[Remote] Technical Program Manager, Foundation Models (Staff / Principal) at Genesis Therapeutics

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Artificial Intelligence, Drug DiscoveryIndustries

Skills

Key technologies and capabilities for this role

Technical Program ManagementFoundation ModelsAIMachine LearningDeep LearningDrug DiscoveryScientific InitiativesEngineering InitiativesResearch RoadmapGenerative ModelsLarge-scale SimulationsCompute ResourcesConfiguration ManagementModel DeploymentProgram ManagementExperiment GovernancePlatform Engineering

Questions & Answers

Common questions about this position

What is the employment type for this role?

This is a full-time position.

Is this role remote or does it require office presence?

This information is not specified in the job description.

What experience is required for this Technical Program Manager role?

A seasoned Technical Program Manager with experience in technical operations, cross-functional execution, managing large-scale compute resources, and implementing configuration management for reproducible research is required.

What is the team culture like at Genesis Therapeutics?

It's a tight-knit team of proven deep learning researchers, software engineers, and drug discovery pioneers focused on revolutionary AI foundation models for therapies, conducting fundamental research at the intersection of machine learning, physics, and computational chemistry.

What makes a strong candidate for this position?

Strong candidates are seasoned Technical Program Managers who can orchestrate end-to-end delivery of foundation models, manage large-scale compute, implement configuration management, drive cross-functional execution, and design operational processes while acting as a communication hub.

Genesis Therapeutics

AI-driven drug discovery for pharmaceuticals

About Genesis Therapeutics

Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to transform the drug discovery process and bring new therapies to market.

Burlingame, CaliforniaHeadquarters

2019Year Founded

$272.5MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program

Risks

Competition from AI-driven companies like Insilico Medicine and Exscientia is increasing.

Over-reliance on partnerships could lead to financial instability if drugs aren't successful.

Rapid AI advancements may render current models like GEMS obsolete without updates.

Differentiation

Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.

The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.

Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.

Upsides

Partnership with NVIDIA enhances GEMS platform for targeting undruggable diseases.

$224 million equity investment boosts research and development capabilities.

Recognition as a 'Fierce 15' company underscores AI's role in breakthrough therapeutics.

Land your dream remote job 3x faster with AI

Try Jobo Free